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Abstract
Purpose Although comorbidities, frailty, and functional im-
pairment are common in older adults (OA)with cancer, little is
known about how these factors are considered during the
treatment decision-making process by OAs, their families,
and health care providers. Our aim was to better understand
the treatment decision process from all these perspectives.
Methods A mixed methods multi-perspective longitudinal
study using semi-structured interviews and surveys with 29
OAs aged ≥70 years with advanced prostate, breast,
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colorectal, or lung cancer, 24 of their family members,13 on-
cologists, and 15 family physicians was conducted. The sam-
ple was stratified on age (70–79 and 80+). All interviews were
analyzed using thematic analysis.
Results There was no difference in the treatment decision-
making experience based on age. Most OAs felt that they
should have the final say in the treatment decision, but strong-
ly valued their oncologists’ opinion. “Trust in my oncologist”
and “chemotherapy as the last resort to prolong life” were the
most important reasons to accept treatment. Families indicated
a need to improve communication between them, the patient
and the specialist, particularly around goals of treatment.
Comorbidity and potential side-effects did not play a major
role in the treatment decision-making for patients, families, or
oncologists. Family physicians reported no involvement in
decisions but desired to be more involved.
Conclusion This first study using multiple perspectives
showed neither frailty nor comorbidity played a role in the
treatment decision-making process. Efforts to improve com-
munication were identified as an opportunity that may en-
hance quality of care.
Condensed abstract In a mixed methods study multiple per-
spective study with older adults with cancer, their family
members, their oncologist and their family physician we ex-
plored the treatment decision making process and found that
most older adults were satisfied with their decision.
Comorbidity, functional status and frailty did not impact the
older adult’s or their family members’ decision.
Keywords Decisionmaking . Aged . Functional status .
Comorbidity .Mixedmethods study . Geriatric oncology
Introduction
Older adults are heterogeneous in terms of health, functional,
psychological, social, and economic status [1]. With increas-
ing age the levels of frailty increase and there is decline in
physiologic function that influences both the risks and benefits
of treatment [2]. Studies show that under-treatment in older
adults with cancer is common and is related to age and comor-
bidities [3–8]. Evidence also shows greater variation in treat-
ments offered by oncologists [9–12] to older adults with de-
clining health, suggesting difficulty in identifying and
recommending the most appropriate treatment for this
population.
A previous systematic review of cancer treatment decision-
making showed that few studies have focused on older adults
aged 70+ [13]. Furthermore, although recent studies explored
factors influencing the treatment decision-making process
from the perspectives of older adults with cancer [14, 15],
none explored the influence of frailty, comorbidity, or func-
tional status while they have been shown to be associated with
treatment tolerability and outcomes [16–18]. In addition, few
studies explored support needed to enhance the quality of the
treatment decision-making process for older adults, their fam-
ily members, oncologists and family physicians. The aims of
this study were to examine the treatment decision-making
process from all four perspectives, as well to explore how




We conducted a mixed method multi-perspective longitudinal
study [19–21]. Older adults with cancer were invited to com-
plete two semi-structured interviews and surveys: one after the
treatment decision had been made [up to six months after the
decision] and one 3–6 months later to allow examination of
changes over time. The other participants (family members,
oncologist and family physician) were invited to participate in
one semi-structured interview. Multi-perspective interviews
were used as they can provide complementary and contradic-
tory perspectives [22].
The study was approved by each participating institution’s
research ethics board. All participants provided written in-
formed consent.
Study participants
Older adults with cancer aged ≥70 with advanced breast, pros-
tate, colorectal, and lung cancer and who made a treatment
decision about palliative chemotherapy in the previous six
months at the Princess Margaret Cancer Centre, University
Health Network or the Odette Cancer Centre, Sunnybrook
Health Sciences Centre, both in Toronto Canada between
July 2014 and August 2015 were eligible.
Purposeful sampling was used to maximize opportunities
to develop concepts and identify relationships among con-
cepts [23]. The process of data collection and analysis was
cyclical to allow time for reflection and opportunity to refine
questions.
The older adult sample was stratified by age (70–79 and
80+) to ensure adequate representation from the oldest adults,
as treatment benefits and risks differ with increasing comor-
bidity, frailty and age. The number of participants was guided
by data saturation in each stratum.
Sixty-seven older adults were invited to participate; 38
agreed and 29 declined. The most common reason for decline
was that the older adult was not interested. Six patients did not
complete the first interview.While 6 agreed to participate they
were not interviewed for various reasons. Reasons included:
change of mind (n = 1), family member disapproval (n = 1), or
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declining health (n = 4). Three patients slightly younger than
70were recruited at the Odette Cancer Centre bymistake; they
were retained as their experiences were similar to other partic-
ipant’s experiences.
At the end of the first older adult interview the other
participants were identified and recruited subsequently.
All but one invited family member participated. Fifteen
family physicians agreed to participate, seven refused and
the other older adults did not have one. Thirteen oncolo-
gists participated and three declined. Eleven older adults
passed away and two withdrew before the second
interview.
Interviews
Semi-structured interviews were conducted using topic
guides (see Supplemental information file 1). The inter-
views included questions about health and treatment rec-
ommendations, factors that influenced the treatment
decision-making process, information needs, support
needs, and the influence of comorbidities and functional
status on the treatment decision-making process. Twenty-
two participants were interviewed by the telephone as per
the patients’ wishes; six were interviewed at home and four
were interviewed in the cancer centers. All family mem-
bers and family physicians were interviewed by telephone.
The oncologists were interviewed in their office. All inter-
views were audio-recorded and transcribed verbatim and
field notes were written to provide context for the inter-
view. Interviews were conducted by the PI and trained
nursing students. Most interviews lasted between 15 and
60 min.
Member checking was used to validate our findings [23]
by sending all participants the summary of their interview
findings with a return envelope for corrections.
Survey and chart data
Older adults were asked to complete a survey after both
interviews to obtain social demographic information, and
information on health, frailty (using the Vulnerable Elder
Survey (VES) -13 items [24]), and the decision making (the
1 item Control Preferences Scale [25] to assess decisional
preferences and Satisfaction with Decision Scale [26]
which is a sum of the six items and ranges 6–30 with higher
scores indicating more satisfaction). Two initial and seven
follow-up surveys were missing for reasons including pa-
tients’ death and not receiving surveys back.
Cancer diagnosis, comorbid conditions and the Eastern
Cooperative Oncology Group performance status [27]
closest to the interview date were abstracted from the chart.
Data analysis
Interviews were transcribed verbatim and analyzed with sup-
port of NVivo v.10 using a thematic analysis approach [28].
The PI and research assistant read the transcripts to explore
emerging themes. We used constant comparison to identify
the themes and data from each perspective. Initially data from
each perspective was analyzed separately and in the next step
as case studies around the older adult [19]. The findings were
discussed with the research team to reach peer consensus.
Descriptive statistics were used to summarize survey
results and describe the characteristics of older adults.
The VES-13 was used to categorize patients into frail
(score of ≥3) and non-frail to explore whether the treat-
ment decision-making process was different.
Results
Twenty-three men and nine women participated (see Table 1
and Supplemental information Table 1). Eighteen were aged
70–79, 11 were aged 80+ and 3 were aged 63–69. Four older
adults had breast cancer, 11 had prostate cancer, six had colo-
rectal cancer, and 11 had lung cancer. Seven patients lived
alone. All participants were satisfied with their treatment
decision-making process using the Satisfaction with
Decision-making scale (mean 25.4 (SD 2.7) for age 70–79
and mean 25.7 (SD 4.5) age 80+). There were 9 persons in
the “young old” group frail (VES-13 score ≥ 3). In the “old
old” group 6 were frail. Of the 27 family members who par-
ticipated in this study, 14 were children, 10 were spouses and
1 was a friend who had become the caregiver. Female partic-
ipants had more often a child as their caregiver (7/9 partici-
pants) compared to the male participants who had more
spouses as caregivers (8/23).
Themes according to participant group
Themes per participant group are reported in Supplemental
information Table 2 with citations and are summarized below.
Older adults
All but four patients accepted the recommended treatment.
There were no differences in the treatment decision-making
process based on age, frailty or comorbidities. The following
three themes to describe the older adults’ treatment decision-
making processes emerged:
Relationship with the oncologist
The most common reason for accepting chemotherapy was
based on their relationship and their trust in the oncologist as
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expert to recommend the best treatment. The older adults
felt that their oncologists were generally supportive and
took the time to explain things to them and answer their
questions. However, about a third of older adults felt that
they were often being rushed by their oncologist and the
appointments were too short to allow them to express their
concerns and ask their questions. One-third of the patients
sought advice from their family physicians regarding their
disease and treatment.
Perceived benefits and harms/discomfort
There were many older adults that accepted the oncolo-
gists’ recommended chemotherapy as they saw chemother-
apy as the last resort to prolong life. Others accepted che-
motherapy to maintain quality of life. Comorbidity and
functional status did not play any role in the treatment
decision-making process for most patients despite some
older adults reporting having several other diseases.
Travel to the hospital did influence decisions of older
adults who were dependent on family.
Treatment experiences of important others/family influences
Four patients described how others’ positive chemothera-
py experiences made them accept chemotherapy, reason-
ing that if it worked for others and they were doing well it
made the decision easier to accept it. Two accepted che-
motherapy because their family told them to accept and
one patient who initially did not want chemotherapy
changed her mind after her family was upset and wanted
her to try it.
Family members
The following themes emerged from interviews with family
members:
Trust in the oncologist
The family members trusted the oncologist to give the best
treatment recommendations based on his/her expertise.
They often searched online for more information. They
were unsatisfied with the opportunities for telephone con-
tact because of the miscommunications or contradicting
information with regard to follow-up care.
Perceived benefits and harms
Family members wanted treatment to prolong life and they
indicated that they were not always clear on what the
intended outcome of the treatment was. They mentioned
that they would like more information about the actual
goal, whether that was reduction in a specific symptom
or stabilizing the disease etc. However, several family




Family physicians reported not being involved in the treat-
ment decision-making process and some voiced that they
would like to be more involved in the care of their patients
and be involved earlier than only being included at the end-
of-life stage. Family physicians reported that patients usu-
ally did not come back for advice regarding treatment.
However, those older adults that did come to see them
often lacked the details on the treatment that was suggested




The majority of the oncologists stated that coming up with
their treatment recommendation was easy and that most pa-
tients did not have a hard time making a decision. Several
oncologists stated that they do take functional status (perfor-
mance status) into consideration when assessing for treatment
suitability. Some oncologists used dose-reduction due to pa-
tients’ age. The challenges of formulating treatment was
balancing risks and benefits of treatment and to help patients,
Table 1 Study participants characteristics
Characteristic Young old: n = 21 Aged 80 years
and older n = 11
Sex
Woman 5 (24 %) 4 (36 %)
Man 16 (76 %) 7 (64 %)
Living alone 5 (24 %) 3 (27 %)
Cancer type
Breast 3 (14 %) 1 (9 %)
Colorectal 4 (19 %) 1 (9 %)
Prostate 7 (33 %) 4 (36 %)
Lung 7 (33 %) 5 (45 %)
Interview with family member 16 (76 %) 9 (82 %)
Interview with oncologist 18 (86 %) 10 (91 %)
Interview with family physician 12 (57.1 %) 6 (55 %)
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particularly for those who were eager for treatment, under-
stand the importance of the risk-benefit balance.
Comparison of the four perspectives
Several discrepancies between the four participant groups
were noted (see Table 2 and Supplemental information
Table 3) and are described below.
Different perspectives on frailty and function
Older adults stated they were in good shape, and reported
no major concerns other than fatigue. Older adults did not
mention frailty. No family member mentioned frailty; al-
though they did often describe a weakened state after
starting chemotherapy. Only one oncologist stated that
the decision about what treatment to recommend was chal-
lenging due to the patient’s frail status.
Different perspectives on comorbidity
Most patients stated they had good health, and denied hav-
ing any major comorbidities. Those with comorbidities
mentioned they were being treated for them and thus co-
morbidity played no role in their treatment decision-
making process. Family members also indicated that co-
morbidities played no role in the treatment decision-
making process. In contrast, some family physicians stated
that comorbidities were often not sufficiently taken into
account in the cancer treatment decision-making process.
Oncologists spoke of most patients as fit patients and
therefore comorbidity had no influence on the treatment
decision-making process. Although several patients denied
having any comorbidities and stated they had good health,
their family physician described these same patients’ as
having multiple comorbidit ies and health issues.
Oncologists did not always mention these multiple comor-
bidities. Despite oncologists and patients reporting good
health there was a substantial proportion who were classi-
fied as frail on the VES-13, which was only due to age
alone (aged 85+) in two patients.
Differences in who made the decision
Almost all patients stated that they made the treatment
decision themselves. However, they also talked about
‘leaving it up to the specialist’. Of note, most older adults
indicated on the Control Preferences Scale a desire to make
their own decision after seriously considering their doc-
tor’s opinion. Oncologists indicated that patients made
their own decisions. Lastly, differences in perspectives
were observed between family members. Spouses of pa-
tients spoke of “his/her decision” because it is “his/her
life” or “his/her body”. These decisions were usually made
in the moment. Contrastingly, children spoke of “we deci-
sions”, and they took time to think and discuss the treat-
ments recommended at home. Children were often more
actively involved in finding additional information about
the treatment decision to be made than spouses.
(Mis)communication
Several older adults and family members voiced their dissat-
isfaction with their family physician due to delays in
diagnosis/wrong diagnoses. However, these family physicians
did not seem to be aware of this dissatisfaction. Some older
adults accepted chemotherapy to ‘get better’ and ‘to cure
Table 2 Summary table of the influence of functional status, frailty and comorbidity on the treatment decision-making process
Domains Older Adult Family member Cancer Specialist Family physician
Functional status Prolonging life is
most important, for
others maintaining




Most patients were fit,
performance status
is taken into account
Not involved
Comorbidity Other health conditions




do not play a role in
the chemotherapy
decision
Comorbidity is taken into
account but most patients
were fit so it did not play
an important role






Frailty Not mentioned by patients Not mentioned by family
members (but they do
describe weakened states
after the start of
chemotherapy)
Not mentioned by all except
one
Not contacted for any
information with regard
to health and functional
status
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cancer’ while these patients were receiving chemotherapy
with palliative intent.
Many oncologists felt that it was not useful to contact fam-
ily physicians as they are not experienced and cannot add
value to the discussion or are not interested. Conversely, some
family physicians felt that they were not given the opportunity
to get involved in the treatment decision-making process nor
included in the discussion regarding patients’ treatment goal,
prognosis, and transition from active treatment to palliative/
end-of-life care.
Suggestions for improvement
While most older adults were satisfied and had few sugges-
tions, several family members (particularly children) and
Table 3 Participants’ Suggestions for Improvement
Patient Family member Oncologist Family physician
• More discussion about financial
support in terms of travel costs
during treatment.
• More written, understandable
information about the
recommended treatment
• More social work access • Improvement on transportation
and home care
• Heads up if next appointment will
involve decision-making so they
can prepare and bring somebody;
also, more time allocated for those
appointments so that all questions
can be asked
•More resources/directions on where
to go online to find reliable
information (e.g. provide a list
of trustworthy websites).
• More support for patient
assessment – no time in
clinic to perform
geriatric assessment (GA)
• More timely information about
diagnosis, treatment (including
actual drug and how it works),
what side effects are and
WHEN do they start
• More clarification of medication terms • More clarification with regard to
medical terminology
• Get family physicians
involved
• Opportunity to participate in
discussion regarding end-of-
life care
• Listen to the patients • Take time to sit down and listen
to patients
• Each patient should be
assigned a care navigator
• To be informed earlier if patients
have no more treatment
options; be informed by
oncologist before hearing it
from the patient
• Nurses need to make more
conversations
• More information on what
treatment
success means
• Be more informed about What
treatment goal is
• Inform other patients that nurses are
a source of support during TDMP
• Clinics should avoid appointment
changes on short notice as it is
very difficult for caregivers to
arrange for time off work to
come to appointments
• A paid patient
navigator/manager
(somebody with healthcare
training such as a retired
professional) should be
assigned
to each patient to help him/her
navigate the system
• Each patient should be assigned a
patient care coordinator/manager/
navigator to help navigate the large,
confusing system, which could be
especially frightening for those who
do not speak English.
• For patients with brain metastases,
more consideration should be
given in terms of who information
is given to (if patient is confused)
• Oncologists need to understand
psychosocial background and
patient wishes
• More continuity in staff support
(i.e. same nurse during each visit)
• Appointment reminders should be
emailed to designated caregivers
rather than to patients
• Oncologists should discuss more
openly treatment goals –
advanced care planning
for patients• Efforts should be made to ensure
that phone numbers given to call for
questions are helpful. Be sure there is
someone to ask when questions arise
• Space and designated room in
hospital for peer support
(for patients and families).
• Better communication and
coordination to prevent
contradicting treatment
possibilities given to patients
(fellows vs. oncologists) to
avoid raising patients’ hopes
only to be disappointed later
when told something different.
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family physicians had several suggestions to improve care.
These are summarized in Table 3.
Changes over time
Half of the older adults were still on the same treatment regimen at
the time of their second interview.Most of themwere feeling better
and noticed an improvement in functional status. All of themwere
satisfied with the information they received to support their treat-
ment decision-making process, including the two patientswho had
to stop chemotherapy due to side effects. All but one patient stated
they would have made the same decision if they were to go
through the same treatment decision again.
Discussion
We interviewed a series of older adultswith advanced cancer along
with their families, oncologists and family physicians to examine
the treatment decision-making process and factors influencing it.
Most accepted the treatment recommended by their oncologist
based on trust. Surprisingly, comorbidity and functional status
were not important factors influencing treatment decisions from
the perspective of patients, families or oncologists in this study.
Our findings that most older adults and families accepted the
treatment recommendation by the oncologist based on trust is in
agreement with earlier studies [13]. The patient’s choice to follow
the oncologists’ suggestions and place their trust in them aligns
with the notion that there may exist a natural developmental ten-
dency for older adults to desire less responsibility for medical
decisions and to rely on the expertise of others. This is in agree-
ment with the Socio-emotional Selectivity Theory (i.e. the selec-
tion and pursuit of goals change as one ages and time becomes
limited [29]). As a result, interest in knowledge pursuit decreases,
and older adults become less interested in problem-solving, plan-
ning, or information. However, this may change with increasing
use of information technology (e.g. the Internet). Furthermore,
only four patients declined the proposed treatment. This may be
due to the two recruitment sites; both cancer centers are the largest
comprehensive cancer centers in Canada and they attract patients
that want a certain treatment not available or not offered in smaller
hospitals as well as patients who want to be treated aggressively
and therefore, are willing to travel to these famous cancer centers.
The decision to initiate chemotherapy in older adults is an
important task facing oncologists and entails considering a number
of factors including life expectancy, treatment benefit and toler-
ance, and availability of social support, along with considerations
to minimize treatment toxicity [30–32]. Recently the use of geri-
atric assessment has been recommended to help make chemother-
apy treatment decisions in older adults [16, 33] by assessing the
level of frailty and functional impairments as well as determining
remaining life expectancy in the context of their other health con-
ditions. Frailty was not a common theme brought up by
oncologists. Many oncologists state that their patients were “fit
enough” to undergo chemotherapy. However, research has shown
that oncologists may overestimate the level of fitness of patients
and that a frailty/geriatric assessment may give a better idea of the
level of functioning of the patient [34] and none of the oncologists
mentioned using any geriatric oncology guidelines or geriatric
assessment tools to inform their treatment recommendation.
Older adults often have a long relationship with their family
physicians whom they trust and who was often the health care
professional investigating the symptoms leading to the cancer
diagnosis and after referral there was a gap in communication.
Improving the communication between the oncologist and family
physician could improve quality of care at every stage of the
disease and treatment as well as smooth transition for patients as
they approach end-of-life [35, 36].
A strength of this study is our multi-perspective qualitative
design and the first to explore the impact of frailty, comorbidity
and function from each perspective. Results showed the advan-
tages of using multiple perspectives as highlighted in the differ-
ences and discrepancies as well as agreements observed.
However, generalizability of study findings must be made with
caution. They were recruited at two highly specialized cancer
centers that may attract different patients compared to other hos-
pitals. Moreover, those who died or were too sick to participate in
the second interview might have had different perspectives in
terms of their satisfaction with the treatment decision-making
process.
In conclusion, patients and family members were largely sat-
isfied with their treatment decision-making process. Efforts to
improve communication between oncologists and family physi-
cians and between oncologists and patient and their families are
needed to enhance the quality of the treatment decision-making
process.
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